Pyomyositis in the United States 2002–2014 - 14/04/20
, Thomas A Melgar a
, Duncan Vos c
, Neiberg Lima b
, Sapna Sadarangani d, e, f 
Highlights |
• | Pyomyositis cases are increasing in the United States. |
• | MSSA is the most commonly identified organism in patients with pyomyositis, followed by MRSA. |
• | Increased association with HIV, types 1 and 2 diabetes mellitus, hematologic malignancy, organ transplant, malnutrition, chronic kidney disease, obesity, and rheumatoid arthritis suggests these as risk factors for pyomyositis in the United States. |
Summary |
Objectives |
Primary pyomyositis is a bacterial infection of skeletal muscle first recognized in tropical regions of the world but needing characterization in temperate climates.
Methods |
This population-based study used the Healthcare Utilization Project/Nationwide Inpatient Sample database to characterize the trends of pyomyositis admissions in the United States from 2002–2014 using ICD-9 diagnostic codes.
Results |
We found a concerning more than three-fold increase in the incident pyomyositis admissions over our study period. The median length of stay was over twice as long compared to other hospitalized patients. Patients with pyomyositis were younger and more likely to be male and Black. There were more cases in the West and South compared to Midwest and Northeast. Age-adjusted odds ratios revealed significant association of pyomyositis with HIV, types 1 and 2 diabetes mellitus, hematologic malignancy, organ transplant, malnutrition, chronic kidney disease, obesity, and rheumatoid arthritis. The most commonly identified bacterial diagnosis was Staphylococcus aureus. Pseudomonas species were the most commonly identified gram-negative bacteria.
Conclusion |
This nationwide review of pyomyositis in the United States suggests a concerning increase in incidence and provides information on the trends, demographics, risk factors, and causative organisms for pyomyositis in the United States.
Le texte complet de cet article est disponible en PDF.Keywords : Pyomyositis, Tropical pyomyositis, Muscle abscess, Epidemiology, MSSA, MRSA
Plan
Vol 80 - N° 5
P. 497-503 - mai 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
